Microbial contamination of domiciliary nebulisers and clinical implications in chronic obstructive pulmonary disease

BMJ Open Respiratory Research

Volumn 1, Issue 1, 2014, Pages

  Jarvis, S ^a   Ind, P W ^a   Thomas, C ^a   Goonesekera, S ^a   Haffenden, R ^b   Abdolrasouli, A ^a   Fiorentino, F ^a   Shiner, R J ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; ARTICLE; BIOFILM; BREATHING MOUTHPIECE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; DISEASE EXACERBATION; ESCHERICHIA COLI; FUSARIUM OXYSPORUM; HOME NEBULIZER; HUMAN; KLEBSIELLA; MEDICAL DEVICE CONTAMINATION; MICROBIAL CONTAMINATION; MICROBIOLOGICAL EXAMINATION; PATHOGEN CLEARANCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; VERY ELDERLY;

EID: 85006660011     PISSN: None     EISSN: 20524439     Source Type: Journal    
DOI: 10.1136/bmjresp-2013-000018     Document Type: Article

References (22)

1. Brocklebank D, Ram F, Wright J, et al. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. Health Technol Assess 2001;5:1–149.
2. Jarvis S, Ind PW, Shiner RJ. Inhaled therapy in elderly COPD patients; time for re-evaluation? Age Ageing 2007;36:213–18.
3. O’Driscoll BR, Kay EA, Taylor RJ, et al. Home nebulizers—can optimal therapy be predicted by laboratory studies. Respir Med 1990;84:471–7.
4. Wilson R, Muers MF. Running a domiciliary nebuliser service. Thorax 1997;52:S104–6.
5. Cohen HA, Kahan E, Cohen Z, et al. Microbial colonization of nebulizers used by asthmatic children. Pediatr Int 2006;48:454–8.
6. Pitchford KC, Corey M, Highsmith AK, et al. Pseudomonas species contamination of cystic fibrosis patients’ home inhalation equipment. J Pediatr 1987;111:212–16.
7. Barnes KL, Clifford R, Holgate ST, et al. Bacterial contamination of home nebuliser. BMJ (Clin Res Ed) 1987;295:812.
8. Higgs CMB, Jones P, Tanser AR. Bacterial contamination of home nebulisers. BMJ (Clin Res Ed) 1987;295:1281–2.
9. MacLaughlin EJ, Raehl CL, Treadway AK, et al. Assessing medication adherence in the elderly—which tools to use in clinical practice? Drugs Aging 2005;22:231–55.
10. Arlt S, Lindner R, Rösler A, et al. Adherence to medication in patients with dementia: predictors and strategies for improvement. Drugs Aging 2008;25:1033–47.
11. Chronic obstructive pulmonary disease (updated) 2013. http://www. nice.org.uk.
12. Reychler G, Leonard A, Van Ossel C, et al. Impact of hypochlorite-based disinfection on bacterial contamination of cystic fibrosis patients’ home-nebulisers. J Hosp Infect 2009;72:351–7.
13. Deschamps D, Soler P, Rosenberg N, et al. Persistent asthma after inhalation of a mixture of sodium hypochlorite and hydrochloric acid. Chest 1994;105:1895–6.
14. Rosenfeld M, Joy P, Nguyen CD, et al. Cleaning home nebulizers used by patients with cystic fibrosis: is rinsing with tap water enough? J Hosp Infect 2001;49:229–30.
15. Chatburn RL, Kallstrom TJ, Bajaksouzian S. A comparison of acetic acid with a quaternary ammonium compound for disinfection of hand-held nebulizers. Respir Care 1988;33:179–87.
16. Blau H, Mussaffi H, Mei Zahav M, et al. Microbial contamination of nebulizers in the home treatment of cystic fibrosis. Child Care Health Dev 2007;33:491–5.
17. Tai C-H, Lin N-T, Peng T-C, et al. Cleaning small-volume nebulizers: the efficacy of different reagents and application methods. J Nurs Res 2011;19:61–7.
18. Pierce AK, Sanford JP, Thomas GD, et al. Long-term evaluation of decontamination of inhalation-therapy equipment and the occurrence of necrotizing pneumonia. New Engl J Med 1970;282:528–31.
19. Martínez-Solano L, Macia MD, Fajardo A, et al. Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease. Clin Infect Dis 2008;47:1526–33.
20. Takigawa K, Fujita J, Negayama K, et al. Nosocomial outbreak of Pseudomonas cepacia respiratory infection in immunocompromised patients associated with contaminated nebulizer devices. Kansenshogaku Zasshi 1993;67:1115–25.
21. Retuerto MA, Szczotka-Flynn L, Ho D, et al. Efficacy of Care Solutions Against Contact Lens-Associated Fusarium Biofilms. Optom Vis Sci 2012;89:382–91.
22. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet 2001;358:135–8.